Menu Close

Trending

Diving deeper into AI discovery, Sanofi signs 5-drug deal with Atomwise
GSK gets June 2023 FDA decision date for momelotinib
End of the line for Sanofi’s SERD amcenestrant as it fails first-line trial
Key Presentations at the Medical Devices & IVD Conference Released
Respiratory Monitoring & AI Technologies

Insights

Video 2a 29_06_2018 no player

ASCO 2018/ ASCO 2018/ Insights/ Oncology/ Video

Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success

, , , , , , , , 0 Comment

Gary Hendler, chairman and CEO of EMEA region for Eisai, talked to Richard Staines at pharmaphorum about findings

X
Eisai’s EMEA CEO Gary Hendler on why quality of life is key to Lenvima’s success
https://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/
RP WP Jan017

Cancer/ Clinical/ Insights/ Oncology/ White Papers/ Whitepapers

From promise to practice: immuno-oncology in action – the new frontier in cancer treatment

0 Comment

Immuno-oncology therapies that harness the body’s own defences to fight off tumours are widely acknowledged as the new

X
From promise to practice: immuno-oncology in action – the new frontier in cancer treatment
https://pharmaphorum.com/whitepapers/from-promise-to-practice-immuno-oncology-in-action-the-new-frontier-in-cancer-treatment/

Login

CONTINUE TO SITE >
X
Close in 10 seconds